Journal of Endocrinology

Papers
(The H4-Index of Journal of Endocrinology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Hepatic RACK1 deletion disturbs lipid and glucose homeostasis independently of insulin resistance125
Blocking FGF23 signaling improves the growth plate of mice with X-linked hypophosphatemia110
A ‘new’ estrogen metabolite: an epoxide of estrone as a sulfated steroid56
PACAP ameliorates the fertility of obese mice through PAC1/PKA/ERK/Nrf2 signal axis51
Consistent and effective method to define the mouse estrous cycle stage by a deep learning-based model51
Soy isoflavones recover pancreatic islet function and prevent metabolic dysfunction in male rats50
Pro-resolving role of glucagon in lipopolysaccharide-induced mice lung neutrophilia32
Litsea glutinosa extract promotes fracture healing and prevents bone loss via BMP2/SMAD1 signaling31
Loss of apoptosis repressor with caspase recruitment domain (ARC) worsens high fat diet-induced hyperglycemia in mice30
100 YEARS OF INSULIN: 100 years of insulin: progress, current perspectives and future challenges29
The emerging role of heterodimerisation and interacting proteins in ghrelin receptor function29
Hypothalamic BMP9 suppresses glucose production by central PI3K/Akt/mTOR pathway28
Advances in preclinical models of prostate cancer for research discovery25
Intercellular contacts affect secretion and biosynthesis of pancreatic islet cells24
100 YEARS OF INSULIN: A brief history of diabetes genetics: insights for pancreatic beta-cell development and function23
Neural gut-to-brain communication for postprandial control of satiation and glucose metabolism22
Antenatal steroids: benefits, risks, and new insights22
Hyperinsulinemia induces early and dyssynchronous puberty in lean female mice19
Incretin-mediated control of cardiac energy metabolism18
GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms18
0.055140972137451